Drug intelligence / Profile preview

Aurolab BSS

Development stage: Unknown
Lead developer: Aurolab
Modality: Small Molecules
Administration: Ophthalmic

Overview

**Aurolab BSS** is a sterile, isotonic balanced salt solution manufactured by Aurolab for extraocular and intraocular irrigation during ophthalmic surgery. It is formulated to approximate the electrolyte environment of aqueous humor and support anatomical and physiological integrity of ocular tissues during procedures including cataract extraction, intraocular lens implantation, corneal surgery, vitrectomy, glaucoma surgery, and retinal surgery. The manufacturer lists sodium chloride, potassium chloride, calcium chloride, magnesium chloride, sodium bicarbonate, and dextrose as components; the solution is supplied as a sterile, pyrogen-free, single-use 500 mL uni-bag. ([aurolab.com](https://aurolab.com/products/aurolab-bss.html))

Brand names: Aurolab BSS

Beyond the preview

Go deeper on Aurolab BSS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aurolab BSS.

Explore the full profile